CountryOfPapers CountryOfPapers
Journal list Promote
verified COP 8,6 · D1 • database Scopus / SJR & DOAJ indexed
OpenNano
United States · Elsevier Inc.
workspace_premium D1 Top 10% — Pharmacology (medical) visibility_off Double blind peer review lock_open Open Access · DOAJ

OpenNano

OpenNano is a journal indexed in SJR in Biotechnology and Internal Medicine with an H index of 30. It is an CC BY-NC-ND Journal with a Double blind peer review review system, and It has a price of 1800 €. The scope of the journal is focused on nanopharmaceutics, nanosized delivery systems, drugs, genes, imaging agents. It has a COP Index of 8,6 (best band D1). It is published in English. It has a COP Index of 8,6.

Publisher: Elsevier Inc.
Category: Biotechnology
Indexation: verifiedScopus / SJR verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
COP Index trending_up
8,6 D1 Top 10%

6 of 216 journals in Pharmacology (medical)

H-index · SJR 30 · 1,056
Acceptance rate pie_chart
45%
Source Acceptance_Rate
Time to publication hourglass_top
12 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
1.800 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR DOAJ

COP Index

8,6

D1 Top 10%

SJR Impact

1,056

H-index

30

Docs (year)

24

Docs 3y

153

Total refs

2177

Cites 3y

1274

Citable 3y

152

Cites/Doc 2y

8.28

Ref/Doc

90.71

Immediate OA

1800 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs